929 related articles for article (PubMed ID: 27120794)
1. miR-675-5p enhances tumorigenesis and metastasis of esophageal squamous cell carcinoma by targeting REPS2.
Zhou YW; Zhang H; Duan CJ; Gao Y; Cheng YD; He D; Li R; Zhang CF
Oncotarget; 2016 May; 7(21):30730-47. PubMed ID: 27120794
[TBL] [Abstract][Full Text] [Related]
2. Expression and clinical significance of REPS2 in human esophageal squamous cell carcinoma.
Zhang H; Duan CJ; Zhang H; Cheng YD; Zhang CF
Asian Pac J Cancer Prev; 2013; 14(5):2851-7. PubMed ID: 23803043
[TBL] [Abstract][Full Text] [Related]
3. microRNA-195-Cdc42 axis acts as a prognostic factor of esophageal squamous cell carcinoma.
Sun N; Ye L; Chang T; Li X; Li X
Int J Clin Exp Pathol; 2014; 7(10):6871-9. PubMed ID: 25400770
[TBL] [Abstract][Full Text] [Related]
4. MiR-455-3p acts as a prognostic marker and inhibits the proliferation and invasion of esophageal squamous cell carcinoma by targeting FAM83F.
Yang H; Wei YN; Zhou J; Hao TT; Liu XL
Eur Rev Med Pharmacol Sci; 2017 Jul; 21(14):3200-3206. PubMed ID: 28770965
[TBL] [Abstract][Full Text] [Related]
5. Down-regulation of miR-30a-3p/5p promotes esophageal squamous cell carcinoma cell proliferation by activating the Wnt signaling pathway.
Qi B; Wang Y; Chen ZJ; Li XN; Qi Y; Yang Y; Cui GH; Guo HZ; Li WH; Zhao S
World J Gastroenterol; 2017 Dec; 23(45):7965-7977. PubMed ID: 29259372
[TBL] [Abstract][Full Text] [Related]
6. Filamin C promotes lymphatic invasion and lymphatic metastasis and increases cell motility by regulating Rho GTPase in esophageal squamous cell carcinoma.
Tanabe K; Shinsato Y; Furukawa T; Kita Y; Hatanaka K; Minami K; Kawahara K; Yamamoto M; Baba K; Mori S; Uchikado Y; Maemura K; Tanimoto A; Natsugoe S
Oncotarget; 2017 Jan; 8(4):6353-6363. PubMed ID: 28031525
[TBL] [Abstract][Full Text] [Related]
7. Eukaryotic translation initiation factor 3B accelerates the progression of esophageal squamous cell carcinoma by activating β-catenin signaling pathway.
Xu F; Xu CZ; Gu J; Liu X; Liu R; Huang E; Yuan Y; Zhao G; Jiang J; Xu C; Chu Y; Lu C; Ge D
Oncotarget; 2016 Jul; 7(28):43401-43411. PubMed ID: 27270324
[TBL] [Abstract][Full Text] [Related]
8. MiR-424-5p participates in esophageal squamous cell carcinoma invasion and metastasis via SMAD7 pathway mediated EMT.
Wang F; Wang J; Yang X; Chen D; Wang L
Diagn Pathol; 2016 Sep; 11(1):88. PubMed ID: 27628042
[TBL] [Abstract][Full Text] [Related]
9. Overexpression of miR-191 Predicts Poor Prognosis and Promotes Proliferation and Invasion in Esophageal Squamous Cell Carcinoma.
Gao X; Xie Z; Wang Z; Cheng K; Liang K; Song Z
Yonsei Med J; 2017 Nov; 58(6):1101-1110. PubMed ID: 29047233
[TBL] [Abstract][Full Text] [Related]
10. MiR-106b-5p regulates esophageal squamous cell carcinoma progression by binding to HPGD.
Yang F; Sun Z; Wang D; Du T
BMC Cancer; 2022 Mar; 22(1):308. PubMed ID: 35317779
[TBL] [Abstract][Full Text] [Related]
11. The CADM2/Akt pathway is involved in the inhibitory effect of miR-21-5p downregulation on proliferation and apoptosis in esophageal squamous cell carcinoma cells.
Li X; Chen D; Li M; Gao X; Shi G; Zhao H
Chem Biol Interact; 2018 May; 288():76-82. PubMed ID: 29680210
[TBL] [Abstract][Full Text] [Related]
12. MiR-296-5p inhibits cell invasion and migration of esophageal squamous cell carcinoma by downregulating STAT3 signaling.
Wang ZZ; Luo YR; Du J; Yu Y; Yang XZ; Cui YJ; Jin XF
Eur Rev Med Pharmacol Sci; 2019 Jun; 23(12):5206-5214. PubMed ID: 31298412
[TBL] [Abstract][Full Text] [Related]
13. RNF113A promotes the proliferation, migration and invasion, and is associated with a poor prognosis of esophageal squamous cell carcinoma.
Wang L; Hou Z; Hasim A; Abuduerheman A; Zhang H; Niyaz M; Awut I; Upur H; Sheyhidin I
Int J Oncol; 2018 Mar; 52(3):861-871. PubMed ID: 29393393
[TBL] [Abstract][Full Text] [Related]
14. Expression and role of anion exchanger 1 in esophageal squamous cell carcinoma.
Shiozaki A; Kudou M; Ichikawa D; Shimizu H; Arita T; Kosuga T; Konishi H; Komatsu S; Fujiwara H; Okamoto K; Kishimoto M; Marunaka Y; Otsuji E
Oncotarget; 2017 Mar; 8(11):17921-17935. PubMed ID: 28160546
[TBL] [Abstract][Full Text] [Related]
15. Downregulation of microRNA-382 is associated with poor outcome of esophageal squamous cell carcinoma.
Qi B; Lu JG; Yao WJ; Chang TM; Qin XG; Ji YH; Wang TY; Liu SG; Li HC; Liu YZ; Zhao BS
World J Gastroenterol; 2015 Jun; 21(22):6884-91. PubMed ID: 26078564
[TBL] [Abstract][Full Text] [Related]
16. Downregulation of MiR-31 stimulates expression of LATS2 via the hippo pathway and promotes epithelial-mesenchymal transition in esophageal squamous cell carcinoma.
Gao Y; Yi J; Zhang K; Bai F; Feng B; Wang R; Chu X; Chen L; Song H
J Exp Clin Cancer Res; 2017 Nov; 36(1):161. PubMed ID: 29145896
[TBL] [Abstract][Full Text] [Related]
17. Identification of microRNAs as novel biomarkers for esophageal squamous cell carcinoma: a study based on The Cancer Genome Atlas (TCGA) and bioinformatics.
Li CY; Zhang WW; Xiang JL; Wang XH; Li J; Wang JL
Chin Med J (Engl); 2019 Sep; 132(18):2213-2222. PubMed ID: 31490264
[TBL] [Abstract][Full Text] [Related]
18. Up-regulated miR-548k promotes esophageal squamous cell carcinoma progression via targeting long noncoding RNA-LET.
Chen Z; Lin J; Wu S; Xu C; Chen F; Huang Z
Exp Cell Res; 2018 Jan; 362(1):90-101. PubMed ID: 29126868
[TBL] [Abstract][Full Text] [Related]
19. Plasma miR-185 is decreased in patients with esophageal squamous cell carcinoma and might suppress tumor migration and invasion by targeting RAGE.
Jing R; Chen W; Wang H; Ju S; Cong H; Sun B; Jin Q; Chu S; Xu L; Cui M
Am J Physiol Gastrointest Liver Physiol; 2015 Nov; 309(9):G719-29. PubMed ID: 26316588
[TBL] [Abstract][Full Text] [Related]
20. MiR-498 in esophageal squamous cell carcinoma: clinicopathological impacts and functional interactions.
Islam F; Gopalan V; Law S; Tang JC; Chan KW; Lam AK
Hum Pathol; 2017 Apr; 62():141-151. PubMed ID: 28188753
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
